Sign inGet started

Stewart Jeffrey Ryan

Insider CIK 1761675 · ABBV SVP, US Commercial Operations

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
ABBV AbbVie Inc. F Tax w/h2026-02-272026-03-0323,812$232.08 $5.53M83,171SEC↗
ABBV AbbVie Inc. A Award deriv2026-02-182026-02-2026,812— $026,812SEC↗
ABBV AbbVie Inc. A Award2026-02-182026-02-2026,063— $079,297SEC↗
ABBV AbbVie Inc. A Award2026-02-182026-02-208,988— $0106,983SEC↗
ABBV AbbVie Inc. A Award2026-02-182026-02-209,432— $097,995SEC↗
ABBV AbbVie Inc. A Award2026-02-182026-02-209,266— $088,563SEC↗
ABBV AbbVie Inc. M Exercise deriv2025-03-312025-04-0225,700$79.02 $2.03M0SEC↗
ABBV AbbVie Inc. S Sale2025-03-312025-04-0225,700$209.49 $5.38M86,366SEC↗
ABBV AbbVie Inc. S Sale2025-03-312025-04-0233,132$210.54 $6.98M53,234SEC↗
ABBV AbbVie Inc. M Exercise2025-03-312025-04-0225,700$79.02 $2.03M112,066SEC↗
ABBV AbbVie Inc. F Tax w/h2025-02-282025-03-0420,226$205.02 $4.15M86,366SEC↗
ABBV AbbVie Inc. A Award deriv2025-02-132025-02-1833,854— $033,854SEC↗
ABBV AbbVie Inc. A Award2025-02-132025-02-189,268— $097,160SEC↗
ABBV AbbVie Inc. A Award2025-02-132025-02-189,432— $0106,592SEC↗
ABBV AbbVie Inc. A Award2025-02-132025-02-1819,111— $080,052SEC↗
ABBV AbbVie Inc. A Award2025-02-132025-02-187,840— $087,892SEC↗
ABBV AbbVie Inc. M Exercise deriv2024-03-182024-03-2026,110$61.36 $1.60M0SEC↗
ABBV AbbVie Inc. S Sale2024-03-182024-03-205,099$179.03 $912.9K88,681SEC↗
ABBV AbbVie Inc. S Sale2024-03-182024-03-2026,110$178.85 $4.67M93,780SEC↗
ABBV AbbVie Inc. S Sale2024-03-182024-03-2027,740$178.69 $4.96M60,941SEC↗
ABBV AbbVie Inc. M Exercise2024-03-182024-03-2026,110$61.36 $1.60M119,890SEC↗
ABBV AbbVie Inc. F Tax w/h2024-02-282024-03-0126,121$178.99 $4.68M93,780SEC↗
ABBV AbbVie Inc. A Award deriv2024-02-152024-02-2039,085— $039,085SEC↗
ABBV AbbVie Inc. A Award2024-02-152024-02-209,268— $0119,901SEC↗
ABBV AbbVie Inc. A Award2024-02-152024-02-2033,042— $093,983SEC↗
ABBV AbbVie Inc. A Award2024-02-152024-02-208,810— $0102,793SEC↗
ABBV AbbVie Inc. A Award2024-02-152024-02-207,840— $0110,633SEC↗
ABBV AbbVie Inc. M Exercise deriv2023-03-132023-03-1521,810$54.86 $1.20M0SEC↗
ABBV AbbVie Inc. S Sale2023-03-132023-03-1531,315$152.27 $4.77M60,941SEC↗
ABBV AbbVie Inc. M Exercise2023-03-132023-03-1521,810$54.86 $1.20M114,066SEC↗
ABBV AbbVie Inc. S Sale2023-03-132023-03-1521,810$152.30 $3.32M92,256SEC↗
ABBV AbbVie Inc. F Tax w/h2023-02-282023-03-0224,910$154.28 $3.84M92,256SEC↗
ABBV AbbVie Inc. A Award deriv2023-02-162023-02-2135,111— $035,111SEC↗
ABBV AbbVie Inc. A Award2023-02-162023-02-217,842— $0117,166SEC↗
ABBV AbbVie Inc. A Award2023-02-162023-02-217,486— $0100,512SEC↗
ABBV AbbVie Inc. A Award2023-02-162023-02-2132,085— $093,026SEC↗
ABBV AbbVie Inc. A Award2023-02-162023-02-218,812— $0109,324SEC↗
ABBV AbbVie Inc. M Exercise deriv2022-03-242022-03-2527,690$58.88 $1.63M0SEC↗
ABBV AbbVie Inc. S Sale2022-03-242022-03-2527,690$159.20 $4.41M60,941SEC↗
ABBV AbbVie Inc. M Exercise2022-03-242022-03-2527,690$58.88 $1.63M88,631SEC↗
ABBV AbbVie Inc. S Sale2022-03-012022-03-0112,659$148.49 $1.88M63,541SEC↗
ABBV AbbVie Inc. S Sale2022-03-012022-03-016,229$147.43 $918.3K76,200SEC↗
ABBV AbbVie Inc. S Sale2022-03-012022-03-012,600$149.04 $387.5K60,941SEC↗
ABBV AbbVie Inc. F Tax w/h2022-02-252022-03-0117,093$149.54 $2.56M82,429SEC↗
ABBV AbbVie Inc. A Award deriv2022-02-172022-02-2237,215— $037,215SEC↗
ABBV AbbVie Inc. A Award2022-02-172022-02-224,176— $070,489SEC↗
ABBV AbbVie Inc. A Award2022-02-172022-02-227,710— $085,685SEC↗
ABBV AbbVie Inc. A Award2022-02-172022-02-2213,837— $099,522SEC↗
ABBV AbbVie Inc. A Award2022-02-172022-02-227,486— $077,975SEC↗
ABBV AbbVie Inc. A Award2022-02-172022-02-2219,209— $066,313SEC↗
ABBV AbbVie Inc. S Sale2021-12-152021-12-172,152$128.00 $275.5K47,104SEC↗
ABBV AbbVie Inc. F Tax w/h2021-12-102021-12-141,713$124.15 $212.7K49,256SEC↗
ABBV AbbVie Inc. S Sale2021-03-012021-03-0213,773$108.59 $1.50M50,969SEC↗
ABBV AbbVie Inc. F Tax w/h2021-02-282021-03-0210,957$107.74 $1.18M64,742SEC↗
ABBV AbbVie Inc. A Award deriv2021-02-182021-02-2243,478— $043,478SEC↗
ABBV AbbVie Inc. A Award2021-02-182021-02-2210,098— $061,067SEC↗
ABBV AbbVie Inc. A Award2021-02-182021-02-227,486— $075,699SEC↗
ABBV AbbVie Inc. A Award2021-02-182021-02-224,176— $068,213SEC↗
ABBV AbbVie Inc. A Award2021-02-182021-02-222,970— $064,037SEC↗
ABBV AbbVie Inc. M Exercise deriv2020-12-292020-12-3125,290— $00SEC↗
ABBV AbbVie Inc. M Exercise2020-12-292020-12-3125,290$51.42 $1.30M76,259SEC↗
ABBV AbbVie Inc. S Sale2020-12-292020-12-3125,290$105.00 $2.66M50,969SEC↗
ABBV AbbVie Inc. F Tax w/h2020-12-102020-12-111,791$108.67 $194.6K50,969SEC↗
ABBV AbbVie Inc. S Sale2020-05-122020-05-1223,024$90.00 $2.07M52,760SEC↗
ABBV AbbVie Inc. F Tax w/h2020-02-282020-03-039,703$85.42 $828.8K75,784SEC↗
ABBV AbbVie Inc. A Award deriv2020-02-202020-02-2449,099— $049,099SEC↗
ABBV AbbVie Inc. A Award2020-02-202020-02-2410,840— $074,431SEC↗
ABBV AbbVie Inc. A Award2020-02-202020-02-243,910— $078,341SEC↗
ABBV AbbVie Inc. A Award2020-02-202020-02-242,970— $081,311SEC↗
ABBV AbbVie Inc. A Award2020-02-202020-02-244,176— $085,487SEC↗
ABBV AbbVie Inc. F Tax w/h2019-12-102019-12-121,713$86.44 $148.1K63,591SEC↗
ABBV AbbVie Inc. P Buy2019-08-162019-08-2015,552$64.44 $1.00M65,304SEC↗
ABBV AbbVie Inc. F Tax w/h2019-02-282019-03-046,907$79.41 $548.5K49,752SEC↗
ABBV AbbVie Inc. A Award deriv2019-02-212019-02-2225,700— $025,700SEC↗
ABBV AbbVie Inc. A Award2019-02-212019-02-225,062— $046,135SEC↗
ABBV AbbVie Inc. A Award2019-02-212019-02-222,970— $056,659SEC↗
ABBV AbbVie Inc. A Award2019-02-212019-02-223,645— $049,780SEC↗
ABBV AbbVie Inc. A Award2019-02-212019-02-223,909— $053,689SEC↗
ABBV AbbVie Inc. A Award2018-12-102018-12-1211,595— $041,073SEC↗
ABBV AbbVie Inc. A Award2018-12-102018-12-1211,595— $041,073SEC↗